The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...

Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...

The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...

Mr Sandhu adds: “Since last year, allergy products containing fexofenadine hydrochloride, such as Histallay, are available ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

ALK will initially focus on bringing neffy® to the markets in Europe and Canada, the world's second and third largest adrenaline autoinjector ("AAI”) markets. In both markets, the product can be added ...

The arrival of spring is traditionally associated with allergies, but the crisp air brought on by autumn’s cooler weather doesn’t necessarily mean everyone can take a breath of relief.

The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...

The UAB Division of Pulmonary, Allergy and Critical Care Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, ...

Air purifiers clean the air in a room by drawing in the air, trapping the airborne pollutants within it, and then pushing filtered, clean air back into the space. Some of these airborne particles ...